Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick L Garcia

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Scientific Reports|December 21, 2017
Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumorsAubrey L Miller, Patrick L Garcia, Joseph G Pressey, et al.
Cancers|July 24, 2021
The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic CancerAubrey L Miller, Patrick L Garcia, Samuel C Fehling, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, ItalyMichele Maio, George Coukos, Soldano Ferrone, et al.
Frontiers in Oncology|January 30, 2018
Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft StudyStuart L Cramer, Aubrey L Miller, Joseph G Pressey, et al.
Molecular Cancer Therapeutics|November 17, 2017
JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of CholangiocarcinomaPatrick L Garcia, Aubrey L Miller, Tracy L Gamblin, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Scientific Reports|December 21, 2017
Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumorsAubrey L Miller, Patrick L Garcia, Joseph G Pressey, et al.
Cancers|July 24, 2021
The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic CancerAubrey L Miller, Patrick L Garcia, Samuel C Fehling, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, ItalyMichele Maio, George Coukos, Soldano Ferrone, et al.
Frontiers in Oncology|January 30, 2018
Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft StudyStuart L Cramer, Aubrey L Miller, Joseph G Pressey, et al.
Molecular Cancer Therapeutics|November 17, 2017
JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of CholangiocarcinomaPatrick L Garcia, Aubrey L Miller, Tracy L Gamblin, et al.
Pageof 3